“In business, cash is oxygen” – Gary Vaynerchuk Psychedelics is a cash-intensive business. Earlier in the week, I wrote about how clinical trials alone cost companies tens, sometimes…
top shroom stocks 2021
Data protection Earlier this week a federal review echoed The Canadian Ministry of Health’s original decision to deny data protection for Johnson & Johnson (JNJ.Q)’s Spravato product, a ketamine-derived…
Death & children’s novels When I think about Amanita Muscaria the first two things that come to mind are death, and children’s novels. Amanita Muscaria is arguably the…
Mushroom enthusiasts Filament Health (FH.NE) is looking at mushroom compounds far beyond just psilocybin as the company is run by actual mushroom enthusiasts with access to a lot of…
More cred Earlier this week Cybin (CYBN.NE) announced a conditional uplisting on the NYSE, and Field Trip (FTRP.T) announced conditional approval to the NASDAQ yesterday. This is a…
SEO I’ve stayed pretty positive with regard to the psychedelics space so far, and while the company I am going to be talking about here isn’t a psychedelics company…
Magnifying the problem When lockdowns first hit back in March 2020 I was pretty sure the capital markets and the psychedelic sector would suffer. It was a burgeoning…
The strongest vertical? Ketamine One Capital (MEDI.NE), a company name that probably would have turned heads only 1 or 2 years ago, but now makes total sense is on…
Natty Filament Health is fresh off a $10 million CAD raise backed by Cannacord that closed yesterday, priced at $0.50 per share. Tomorrow they will make the shift to…
In the cannabis sector, there is a wide net of different types of companies from growers to extractors to logistics & tech and everything in-between. In the earlier days…